15566594

Source:http://linkedlifedata.com/resource/pubmed/id/15566594

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031842, umls-concept:C0055477, umls-concept:C1280500, umls-concept:C1719672
pubmed:issue	6
pubmed:dateCreated	2004-11-29
pubmed:abstractText	The purpose of the present study was to evaluate the effects of intravenous lornoxicam on haemodynamic and biochemical parameters, serum cytokine levels and patient outcomes in severe sepsis.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-10225537, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-10321658, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-10450786, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-10643694, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-10834708, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-11028559, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-11504677, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-11504678, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-11770048, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-12660439, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-12879104, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-1597042, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-1867521, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-1898844, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-1952438, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-3690813, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-3928249, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-7525853, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-7836930, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8361173, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8457980, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8507112, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8706598, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8792060, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8797133, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-8844239, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9064348, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9070471, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9187606, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9249645, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9715175, http://linkedlifedata.com/resource/pubmed/commentcorrection/15566594-9751091
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9801902
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 1, http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Piroxicam, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/lornoxicam
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1466-609X
pubmed:author	pubmed-author:Karamanlio?luBeyhanB, pubmed-author:KoyuncuOnurO, pubmed-author:Memi?DilekD, pubmed-author:PamukçuZaferZ, pubmed-author:TuranAlparslanA
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	R474-82
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15566594-APACHE, pubmed-meshheading:15566594-Adult, pubmed-meshheading:15566594-Aged, pubmed-meshheading:15566594-Aged, 80 and over, pubmed-meshheading:15566594-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:15566594-Cyclooxygenase 1, pubmed-meshheading:15566594-Cyclooxygenase 2, pubmed-meshheading:15566594-Cytokines, pubmed-meshheading:15566594-Female, pubmed-meshheading:15566594-Hemodynamics, pubmed-meshheading:15566594-Humans, pubmed-meshheading:15566594-Inflammation, pubmed-meshheading:15566594-Intensive Care Units, pubmed-meshheading:15566594-Male, pubmed-meshheading:15566594-Middle Aged, pubmed-meshheading:15566594-Multiple Organ Failure, pubmed-meshheading:15566594-Piroxicam, pubmed-meshheading:15566594-Placebos, pubmed-meshheading:15566594-Respiration, Artificial, pubmed-meshheading:15566594-Sepsis, pubmed-meshheading:15566594-Severity of Illness Index, pubmed-meshheading:15566594-Treatment Outcome
pubmed:year	2004
pubmed:articleTitle	Effects of lornoxicam on the physiology of severe sepsis.
pubmed:affiliation	Department of Anaesthesiology and Reanimation, Medical Faculty, Trakya University, Edirne, Turkey. dilmemis@mynet.com
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial